ClinVar Miner

Submissions for variant NM_014000.3(VCL):c.2862_2864del (p.Leu955del)

dbSNP: rs397517237
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section,National Institutes of Health RCV000171847 SCV000050868 likely benign Primary dilated cardiomyopathy 2018-04-05 criteria provided, single submitter research
Laboratory for Molecular Medicine,Mass General Brigham Personalized Medicine RCV000038819 SCV000062497 likely benign not specified 2015-04-20 criteria provided, single submitter clinical testing p.Leu955del in exon 19 of VCL: This variant is not expected to have clinical sig nificance because it has been identified in 0.5% (50/10406) of African chromosom es by the Exome Aggregation Consortium (ExAC,; db SNP rs397517237).
GeneDx RCV000727177 SCV000236498 likely benign not provided 2021-06-22 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 24062880, 11815424, 27532257, 24503780, 23861362, 16236538)
Invitae RCV000988386 SCV000289915 benign Dilated cardiomyopathy 1W 2021-12-17 criteria provided, single submitter clinical testing
Eurofins NTD LLC (GA) RCV000727177 SCV000706354 uncertain significance not provided 2017-02-09 criteria provided, single submitter clinical testing
Ambry Genetics RCV000619949 SCV000736360 likely benign Cardiovascular phenotype 2018-10-18 criteria provided, single submitter clinical testing Other strong data supporting benign classification
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000727177 SCV000884872 uncertain significance not provided 2019-12-09 criteria provided, single submitter clinical testing The VCL c.2862_2864del; p.Leu955del variant (rs397517237) is reported in the literature in three individuals who were diagnosed with cardiomyopathy or hyperdynamic left ventricular function (Ng 2013, Olson 2002, and Walsh 2017); however, inheritance and detailed clinical information were not reported for these individuals. This variant deletes a single leucine residue leaving the rest of the protein in-frame. While functional studies demonstrate that the p.Leu955del variant alters actin filament organization, the clinical relevance of these observations is unclear (Olson 2002). The p.Leu955del variant found in the African population with an allele frequency of 0.45% (112/24974 alleles, including a single homozygote) in the Genome Aggregation Database, and is listed in ClinVar with conflicting interpretations of pathogenicity (Variation ID: 45602). Therefore, based on the available information, the clinical significance of the p.Leu955del variant cannot be determined with certainty. References: Ng et al. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. Olson et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation. 2002 Jan 29;105(4):431-7. Walsh et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017 Feb;19(2):192-203.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000038819 SCV000918336 likely benign not specified 2018-05-30 criteria provided, single submitter clinical testing Variant summary: VCL c.2862_2864delGTT (p.Leu955del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 0.0004 in 278208 control chromosomes, predominantly at a frequency of 0.0045 within the African subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within African control individuals in the gnomAD database is approximately 180-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in VCL causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African origin. The variant, c.2862_2864delGTT, has been reported in the literature in individuals affected with Cardiomyopathy (Ng_2013, Olson_2002, Walsh_2017, Pugh_DSC2_GIM_2014). These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Olson_2002). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (likely benign x4, VUS x1, benign x1). Based on the evidence outlined above, the variant was classified as likely benign.
Mendelics RCV000988386 SCV001138087 uncertain significance Dilated cardiomyopathy 1W 2019-05-28 criteria provided, single submitter clinical testing
OMIM RCV000988386 SCV000033224 pathogenic Dilated cardiomyopathy 1W 2002-01-29 no assertion criteria provided literature only
Clinical Molecular Genetics Laboratory,Johns Hopkins All Children's Hospital RCV000678764 SCV000804943 uncertain significance Dilated cardiomyopathy with left ventricular noncompaction 2015-10-01 no assertion criteria provided clinical testing
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000727177 SCV001548885 uncertain significance not provided no assertion criteria provided clinical testing The VCL p.Leu955del variant was identified in 2 of 2440 proband chromosomes (frequency: 0.00082) from individuals or families with arrhythmia, cardiomyopathy, or a family history of sudden death and was not identified in 1000 control chromosomes from healthy individuals (Olson_2002_PMID:11815424; Ng_2013_PMID:23861362). The variant was also identified in dbSNP (ID: rs397517237) and ClinVar (classified as a VUS by three submitters, likely benign by five submitters and benign by Invitae ) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 115 of 282866 chromosomes (1 homozygous) at a frequency of 0.000407 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 112 of 24974 chromosomes (freq: 0.004485), Other in 1 of 7226 chromosomes (freq: 0.000138) and Latino in 2 of 35440 chromosomes (freq: 0.000056), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish), or South Asian populations. This variant is an in-frame deletion resulting in the removal of a leucine (leu) residue at codon 955; the impact of this alteration on VCL protein function is not known. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.
Clinical Genetics, Academic Medical Center RCV000038819 SCV002034724 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000727177 SCV002038011 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.